SpyGlass Pharma SGP
NASDAQ SGP
$34.18 -4.19 (-10.92%)
At close: Nov 10, 2026 · 4:00 PM EST

SpyGlass Pharma (SGP) Cash from Financing Activities (2025 - 2026)

Updated

SpyGlass Pharma (SGP) recorded Cash from Financing Activities of $124.59 million in FY2025, compared with $185,000 in FY2024.

Analysis

SpyGlass Pharma (SGP) Cash from Financing Activities (2025 - 2026) Analysis & Trends

  • Per Business Quant data, SGP's Cash from Financing Activities was $185,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 SpyGlass Pharma 1.14 Bn 534.30 Mn - 13,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13,000.00
Mar 31, 2026 157.76 Mn
Jun 30, 2025 75.61 Mn
Mar 31, 2025 50.10 Mn
API Access

SpyGlass Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SGP&period=max&api_key=YOUR_API_KEY